Figure 8. Relationship between TMX family genes expression and drug sensitivity. TMX1 expression was negatively correlated with drug sensitivity of Bosutinib (A), EGF-816 (B), CP-724714 (C), Osimertinib (D), and Gefitinib (E). TMX2 expression was positively correlated with the drug sensitivity of KHK-Indazole (F), TYROTHRICIN (G), IDF-11774 (H), ARTENIMOL (I), and negatively correlated with the drug sensitivity of PI-103 (J). TMX3 expression was negatively correlated with the drug sensitivity of Fluorouracil (K), and was positively correlated with the drug sensitivity of Lovastatin (L), Simvastatin (M), Midostaurin (N), Binrinapant (O). TMX4 expression was negatively correlated with the sensitivity of brigatinib (P), TPX-0005 (Q), Dasatinib (R), Ly-2874455 (S), but positively correlated with the drug sensitivity of Ganetespib (T).